These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9471197)

  • 1. [The effects of thymostimulin in a protocol of concurrent hyperfractionated carboplatin and irradiation].
    De Serdio JL; Villar A; Alvarez IE; Gil-Cubelo JA; Suñer M; Hernández R; López-Aguado D
    Acta Otorrinolaringol Esp; 1997; 48(6):487-92. PubMed ID: 9471197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Auditory assessment in a protocol of concurrent carboplatin and irradiation use in fractionated therapy].
    De Serdio JL; Villar A; Halawa BF; González-Castro I; Alvarez IE; Artazkoz JJ; López-Aguado D
    Acta Otorrinolaringol Esp; 1997; 48(8):614-9. PubMed ID: 9528133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction with erythropoietin.
    Villar A; Martinez JC; de Serdio JL
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1382-8. PubMed ID: 18037586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperfractionated chemoradiation with carbogen breathing, with or without erythropoietin: a stepwise developed treatment schedule for advanced head-and-neck cancer.
    Martinez JC; Villar A; Cabezon MA; de Serdio JL; Fuentes C; Espiñeira M; Perez MD; Gil J; Artazkoz JJ; Borque C; Suñer M; Saavedra JA
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):47-53. PubMed ID: 11316545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.
    Brizel DM; Albers ME; Fisher SR; Scher RL; Richtsmeier WJ; Hars V; George SL; Huang AT; Prosnitz LR
    N Engl J Med; 1998 Jun; 338(25):1798-804. PubMed ID: 9632446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concomitant hyperfractionation of drugs and irradiation in the treatment of advanced ENT cancers].
    de Serdio JL; Villar A; Halawa BF; Cejas L; de Miguel B; Martín JJ; López-Aguado D
    An Otorrinolaringol Ibero Am; 1998; 25(2):147-65. PubMed ID: 9607225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck.
    Jeremic B; Milicic B; Dagovic A; Vaskovic Z; Tadic L
    J Clin Oncol; 2004 Sep; 22(17):3540-8. PubMed ID: 15337803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin and radiotherapy in the treatment of head and neck cancer: six years' experience.
    Zamboglou N; Schnabel T; Kolotas C; Achterrath W; Strehl H; Dalhäuser S; Vogt HG; Lenaz L; Schmitt G
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):45-53. PubMed ID: 7992066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of hyperfractionated accelerated radiation and simultaneous Carboplatin therapy for advanced head and neck carcinomas.
    Schnabel T; Zamboglou N; Kolotas C; Jiménez W; Strehl H; Schmitt G
    Strahlenther Onkol; 1992 Jun; 168(6):318-21. PubMed ID: 1621209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated accelerated radiotherapy with concurrent carboplatin for locally advanced squamous cell carcinoma of the head and neck.
    Chan AK; Sanghera P; Choo BA; McConkey C; Mehanna H; Parmar S; Pracy P; Glaholm J; Hartley A
    Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):34-9. PubMed ID: 20863676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined radiochemotherapy with carboplatin in the treatment of advanced head and neck carcinomas.
    Schnabel T; Zamboglou N; Kolotas C; Hartmann A; Schmitt G
    Oncology; 1993 Nov; 50 Suppl 2():16-22. PubMed ID: 8233296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin-based concurrent chemoradiation therapy in locally advanced head and neck cancer patients who are unfit for cisplatin therapy.
    Noronha V; Sharma V; Joshi A; Patil VM; Laskar SG; Prabhash K
    Indian J Cancer; 2017; 54(2):453-457. PubMed ID: 29469077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current results of the treatment of cervical metastatic lymph nodes by concurrent hyperfractionation of carboplatin and irradiation].
    de Serdio JL; Villar A; Cejas L; Gil JA; Alvarez IE; Martínez JC; Pérez-Suárez MD
    Acta Otorrinolaringol Esp; 1998 Oct; 49(7):554-60. PubMed ID: 9866222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of infection and improvement of cenesthesia with thymostimulin during chemotherapy following mastectomy].
    Alba E; Visentin L; Farina C; Wierdis T
    Minerva Ginecol; 1991 Dec; 43(12):585-7. PubMed ID: 1819777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II study on hyperfractionated chemoradiation using chemotherapy as part of each fraction of treatment in locally far advanced head and neck cancer.
    Villar A; Martínez JC; Pérez MD; de Serdio JL; Gil-Curbelo J; Fuentes C; Espiñeira M; Alawa BH; Alvarez E; Saavedra JA
    Eur J Cancer B Oral Oncol; 1995 Nov; 31B(6):401-2. PubMed ID: 8746273
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction chemotherapy followed by hyperfractionated radiotherapy with concurrent chemotherapy for locally advanced head and neck cancer.
    Karasawa K; Shinoda H; Katsui K; Seki K; Kohno M; Hanyu N; Nasu S; Muramatsu H; Maebayashi K; Mitsuhashi N; Yoshihara T
    Anticancer Res; 2003; 23(6D):5031-6. PubMed ID: 14981963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.